glycobrom: Glycopyrronium Bromide dose-response data
Description
Data from a clinical study evaluating Efficacy and Safety of Four
Doses of Glycopyrronium Bromide in Patients With Stable Chronic
Obstructive Pulmonary Disease (COPD). This data set was obtained from
clinicaltrials.gov (NCT00501852). The primary endpoint is the trough
forced expiratory volume in 1 second (FEV1) following 7 days of
Treatment.
The data given here are summary estimates (least-square means) for
each dose.source
http://clinicaltrials.gov/ct2/show/results/NCT00501852